UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 64

Sortiert nach

Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non–Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 2007-03, Vol.99 (6), p.442-450

2007

Volltextzugriff (PDF)

Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975

Annals of oncology, 2006-11, Vol.17 (11), p.1698-1704

2006

Volltextzugriff (PDF)

A patient with simultaneously appearing adenocarcinoma and small-cell lung carcinoma harbouring an identical EGFR exon 19 mutation

Annals of oncology, 2012-12, Vol.23 (12), p.3188-3189

2012

Volltextzugriff (PDF)

A randomized phase II study comparing paclitaxel–carboplatin–bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)

Annals of oncology, 2015-11, Vol.26 (11), p.2286-2293

2015

Volltextzugriff (PDF)

A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study

Annals of oncology, 2013-11, Vol.24 (11), p.2860-2865

2013

Volltextzugriff (PDF)

Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin–gemcitabine or carboplatin–paclitaxel: NVALT-3 a phase III study

Annals of oncology, 2011-07, Vol.22 (7), p.1520-1527

2011

Volltextzugriff (PDF)

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

The New England journal of medicine, 2018-06, Vol.378 (24), p.2288-2301

2018

Volltextzugriff (PDF)

COPD in cancer patients: Higher prevalence in the elderly, a different treatment strategy in case of primary tumours above the diaphragm, and a worse overall survival in the elderly patient

European journal of cancer (1990), 2007-10, Vol.43 (15), p.2194-2202

2007

Volltextzugriff (PDF)

Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial

The lancet oncology, 2010-07, Vol.11 (7), p.619-626

2010

Volltextzugriff (PDF)

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

The New England journal of medicine, 2014-12, Vol.371 (23), p.2167-2177

2014

Volltextzugriff (PDF)

A randomised phase II trial of docetaxel vs docetaxel and irinotecan in patients with stage IIIb-IV non-small-cell lung cancer who failed first-line treatment

British journal of cancer, 2005-01, Vol.92 (1), p.15-20

2005

Volltextzugriff (PDF)

Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study

Annals of oncology, 2001-10, Vol.12 (10), p.1359-1368

2001

Volltextzugriff (PDF)

A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer

British journal of cancer, 1998-01, Vol.77 (2), p.347-351

1998

Volltextzugriff (PDF)

Negligible influence of comorbidity on prognosis of patients with small cell lung cancer: A population-based study in the Netherlands

Critical reviews in oncology/hematology, 2007-05, Vol.62 (2), p.172-178

2007

Volltextzugriff (PDF)

The value of [ 18F]fluoro-2-deoxy- d-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment

Lung cancer (Amsterdam, Netherlands), 2003-02, Vol.39 (2), p.151-157

2003

Volltextzugriff (PDF)

Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer: an EORTC phase II study (EORTC 08958)

European journal of cancer (1990), 2003-07, Vol.39 (10), p.1416-1422

2003

Volltextzugriff (PDF)

Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984)

European journal of cancer (1990), 2006-07, Vol.42 (10), p.1399-1406

2006

Volltextzugriff (PDF)

Three-Arm Randomized Study of Two Cisplatin-Based Regimens and Paclitaxel Plus Gemcitabine in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group—EORTC 08975

Journal of clinical oncology, 2003-11, Vol.21 (21), p.3909-3917

2003

Volltextzugriff (PDF)

Prognostic Relevance of Response Evaluation Using [18F]-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Patients With Locally Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2005-11, Vol.23 (33), p.8362-8370

2005

Volltextzugriff (PDF)

Prevention of Chemotherapy-Induced Febrile Neutropenia by Prophylactic Antibiotics Plus or Minus Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer: A Dutch Randomized Phase III Study

Journal of clinical oncology, 2005-11, Vol.23 (31), p.7974-7984

2005

Volltextzugriff (PDF)

Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease)

British journal of cancer, 2006-08, Vol.95 (4), p.470-474

2006

Volltextzugriff (PDF)

Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923)

Annals of oncology, 2003-02, Vol.14 (2), p.248-257

2003

Volltextzugriff (PDF)

Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy

British journal of cancer, 2001-11, Vol.85 (10), p.1456-1461

2001

Volltextzugriff (PDF)

Flare-up of rheumatoid arthritis during GM-CSF treatment after chemotherapy

The Lancet (British edition), 1991-08, Vol.338 (8765), p.517-518

1991

Volltextzugriff (PDF)

Standard Versus Intensified Chemotherapy With Granulocyte Colony-Stimulating Factor Support in Small-Cell Lung Cancer: A Prospective European Organization for Research and Treatment of Cancer–Lung Cancer Group Phase III Trial—08923

Journal of clinical oncology, 2002-10, Vol.20 (19), p.3947-3955

2002

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(64)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(64)
Middle Aged
(61)
Life Sciences & Biomedicine
(56)
Science & Technology
(56)
Male
(54)
Adult
(53)
Aged
(52)
Biological And Medical Sciences
(44)
Medical Sciences
(43)
Oncology
(32)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(24)
Pharmacology. Drug Treatments
(24)
Lung Neoplasms - Drug Therapy
(23)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(21)
Antineoplastic Agents
(20)
Survival Analysis
(20)
Chemotherapy
(18)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(16)
Disease-Free Survival
(16)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non–Small-Cell Lung Cancer

Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975

A patient with simultaneously appearing adenocarcinoma and small-cell lung carcinoma harbouring an identical EGFR exon 19 mutation

A randomized phase II study comparing paclitaxel–carboplatin–bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)

A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study

Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin–gemcitabine or carboplatin–paclitaxel: NVALT-3 a phase III study

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

COPD in cancer patients: Higher prevalence in the elderly, a different treatment strategy in case of primary tumours above the diaphragm, and a worse overall survival in the elderly patient

Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

A randomised phase II trial of docetaxel vs docetaxel and irinotecan in patients with stage IIIb-IV non-small-cell lung cancer who failed first-line treatment

Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study

A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer

Negligible influence of comorbidity on prognosis of patients with small cell lung cancer: A population-based study in the Netherlands

The value of [ 18F]fluoro-2-deoxy- d-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment

Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer: an EORTC phase II study (EORTC 08958)

Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984)

Three-Arm Randomized Study of Two Cisplatin-Based Regimens and Paclitaxel Plus Gemcitabine in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group—EORTC 08975

Prognostic Relevance of Response Evaluation Using [18F]-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Patients With Locally Advanced Non–Small-Cell Lung Cancer

Prevention of Chemotherapy-Induced Febrile Neutropenia by Prophylactic Antibiotics Plus or Minus Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer: A Dutch Randomized Phase III Study

Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease)

Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923)

Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy

Flare-up of rheumatoid arthritis during GM-CSF treatment after chemotherapy

Standard Versus Intensified Chemotherapy With Granulocyte Colony-Stimulating Factor Support in Small-Cell Lung Cancer: A Prospective European Organization for Research and Treatment of Cancer–Lung Cancer Group Phase III Trial—08923

Aktive Filter

Suchergebnisse filtern